Kodiak Sciences Inc
Clinical trials sponsored by Kodiak Sciences Inc, explained in plain language.
Ophthalmology biotech focused on retinal disease treatments.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New eye drug aims to restore vision in Inflammation-Related swelling
Disease control Recruiting nowThis phase 3 trial tests an experimental drug called tabirafusp alfa (KSI-101) given as an eye injection for people with macular edema (swelling) caused by inflammation. The study will compare the drug to a sham (fake) injection in 600 participants to see if it improves vision an…
Phase: PHASE3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New eye drug aims to restore vision in inflammatory swelling
Disease control Recruiting nowThis study tests an experimental drug called tabirafusp alfa (KSI-101) given as an eye injection to treat macular edema (swelling in the back of the eye) caused by inflammation. About 300 adults with vision loss from this condition will receive either the drug or a sham injection…
Phase: PHASE3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC